Literature DB >> 17114460

Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion.

Ju Ho Youn1, Jeon-Soo Shin.   

Abstract

The high mobility group box 1 (HMGB1) protein can be secreted by activated monocytes and macrophages and functions as a late mediator of sepsis. HMGB1 contains two nuclear localization signals (NLSs) for controlled nuclear transport, and acetylation of both NLSs of HMGB1 is involved in nuclear transport toward secretion. However, phosphorylation of HMGB1 and its relation to nuclear transport have not been shown. We show here that HMGB1 is phosphorylated and dynamically shuttled between cytoplasmic and nuclear compartments according to its phosphorylation state. Phosphorylation of HMGB1 was detected by metabolic labeling and Western blot analysis after treatments with TNF-alpha and okadaic acid, a phosphatase inhibitor. Hyperphosphorylated HMGB1 in RAW 264.7 and human monocytes was relocated to the cytoplasm. In a nuclear import assay, phosphorylated HMGB1 in the cytoplasm did not enter the nucleus. We mutated serine residues of either or both NLSs of HMGB1 to glutamic acid to simulate a phosphorylated state and examined the binding of HMGB1 to karyopherin-alpha1, which was identified as the nuclear import protein for HMGB1 in this study. Substitution to glutamic acid in either NLSs decreased the binding with karyopherin-alpha1 by approximately 50%; however, substitution of both NLSs showed no binding, and HMGB1 was relocated to the cytoplasm and subsequently secreted. These data support the hypothesis that HMGB1 could be phosphorylated and that the direction of transport is regulated by phosphorylation of both NLS regions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17114460     DOI: 10.4049/jimmunol.177.11.7889

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  147 in total

1.  Immunomodulatory drugs regulate HMGB1 release from activated human monocytes.

Authors:  Hanna Schierbeck; Heidi Wähämaa; Ulf Andersson; Helena Erlandsson Harris
Journal:  Mol Med       Date:  2010-04-09       Impact factor: 6.354

Review 2.  HMGB1 and microparticles as mediators of the immune response to cell death.

Authors:  David S Pisetsky; Julie Gauley; Anirudh J Ullal
Journal:  Antioxid Redox Signal       Date:  2011-05-05       Impact factor: 8.401

3.  Intracellular HMGB1 negatively regulates efferocytosis.

Authors:  Sami Banerjee; Andressa de Freitas; Arnaud Friggeri; Jaroslaw W Zmijewski; Gang Liu; Edward Abraham
Journal:  J Immunol       Date:  2011-09-28       Impact factor: 5.422

Review 4.  Regulation of Posttranslational Modifications of HMGB1 During Immune Responses.

Authors:  Yiting Tang; Xin Zhao; Daniel Antoine; Xianzhong Xiao; Haichao Wang; Ulf Andersson; Timothy R Billiar; Kevin J Tracey; Ben Lu
Journal:  Antioxid Redox Signal       Date:  2016-02-05       Impact factor: 8.401

5.  PCV2 Induces Reactive Oxygen Species To Promote Nucleocytoplasmic Translocation of the Viral DNA Binding Protein HMGB1 To Enhance Its Replication.

Authors:  Renjie Sun; Siqi Sun; Yikai Zhang; Yingshan Zhou; Ying Shan; Xiaoliang Li; Weihuan Fang
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

Review 6.  Post-translational modifications of high mobility group box 1 and cancer.

Authors:  Seidu A Richard; Yuanyuan Jiang; Lu Hong Xiang; Shanshan Zhou; Jia Wang; Zhaoliang Su; Huaxi Xu
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

7.  HMGB1 Binds to Lipoteichoic Acid and Enhances TNF-α and IL-6 Production through HMGB1-Mediated Transfer of Lipoteichoic Acid to CD14 and TLR2.

Authors:  Man Sup Kwak; Mihwa Lim; Yong Joon Lee; Hyun Sook Lee; Young Hun Kim; Ju Ho Youn; Ji Eun Choi; Jeon-Soo Shin
Journal:  J Innate Immun       Date:  2015-02-05       Impact factor: 7.349

Review 8.  High mobility group proteins and their post-translational modifications.

Authors:  Qingchun Zhang; Yinsheng Wang
Journal:  Biochim Biophys Acta       Date:  2008-05-10

Review 9.  High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation.

Authors:  Shu Zhu; Wei Li; Mary F Ward; Andrew E Sama; Haichao Wang
Journal:  Inflamm Allergy Drug Targets       Date:  2010-03

10.  JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation.

Authors:  Ben Lu; Daniel J Antoine; Kevin Kwan; Peter Lundbäck; Heidi Wähämaa; Hanna Schierbeck; Melissa Robinson; Marieke A D Van Zoelen; Huan Yang; Jianhua Li; Helena Erlandsson-Harris; Sangeeta S Chavan; Haichao Wang; Ulf Andersson; Kevin J Tracey
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.